Ascendis Pharma files patent for ocular drug delivery system using cross-linked Ha
Discover Ascendis Pharma's innovative patent for hydrogel prodrug compositions using cross-linked hyaluronic acid to treat ocular conditions. Learn about the groundbreaking method for administering the drug conjugate and its potential impact on treating AMD, DR, RVO, and more.
Discover Ascendis Pharma's innovative patent for hydrogel prodrug compositions using cross-linked hyaluronic acid to treat ocular conditions. Learn about the groundbreaking method for administering the drug conjugate and its potential impact on treating AMD, DR, RVO, and more.
What's Your Reaction?
